New antibiotic pouch aims to stop infections in heart device patients

NCT ID NCT06854081

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is tracking 100 adults who receive an EluPro antibiotic-eluting envelope during implantation of a heart device (like a pacemaker). The envelope slowly releases antibiotics to prevent infection. Researchers are monitoring complication rates in real-world use to see how safe and effective it is.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
EluPro Antibiotic-Eluting BioEnvelope (a mesh pouch that releases antibiotics around a heart device)
What this could lead to
If successful, this could show that the EluPro envelope helps prevent infections in people with implanted heart devices, leading to safer procedures.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the envelope works better than standard care. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARRHYTHMIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brigham & Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Penn Presbyterian Medical Center

    Philadelphia, Pennsylvania, 19104, United States

  • Tallahassee Research Institute

    Tallahassee, Florida, 32308, United States

  • UC San Diego Health

    La Jolla, California, 92037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.